3:36 PM
 | 
Nov 21, 2012
 |  BC Extra  |  Company News

Ablynx, Algeta in cancer Nanobodies deal

Ablynx N.V. (Euronext:ABLX) and Algeta ASA (OSE:ALGETA) partnered to evaluate a targeted thorium conjugate (TTC) of Algeta's thorium-227, an alpha-particle...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >